The Centers for Medicare & Medicaid Services announced that Medicaid recipients will pay reduced prices for 15 prescription drugs starting in 2027, including Ozempic, Wegovy, and cancer treatments such as Xtandi and Ibrance.CMS Administrator Mehmet Oz highlighted these reductions as significant for taxpayers and Medicare seniors, following the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.